William Plovanic
Stock Analyst at Canaccord Genuity
(3.50)
# 814
Out of 4,829 analysts
129
Total ratings
43.59%
Success rate
5.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Buy | $152 → $139 | $137.70 | +0.94% | 10 | May 2, 2025 | |
| DXCM DexCom | Maintains: Buy | $103 → $106 | $84.67 | +25.19% | 6 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $58 → $59 | $22.98 | +156.75% | 4 | May 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $71 → $75 | $73.68 | +1.79% | 26 | Apr 25, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $4.77 | +277.36% | 8 | Apr 8, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 | $5.02 | +119.12% | 4 | Mar 28, 2025 | |
| ATRC AtriCure | Maintains: Buy | $66 → $52 | $31.00 | +67.74% | 11 | Mar 28, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $104 | $111.50 | -6.73% | 5 | Mar 11, 2025 | |
| STIM Neuronetics | Maintains: Buy | $5 → $8 | $4.43 | +80.59% | 3 | Mar 5, 2025 | |
| CBLL CeriBell | Maintains: Buy | $33 | $15.97 | +106.64% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $101 | $55.82 | +80.94% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $310.67 | -2.15% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $102.86 | -1.81% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $6.68 | +124.55% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $9.11 | +31.72% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $115 | $95.21 | +20.79% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $297.32 | -4.48% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $12.21 | +104.75% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $3.37 | +256.08% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $95.83 | -26.95% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $19.42 | +147.17% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $3.89 | +465.55% | 3 | Jul 25, 2023 |
iRhythm Technologies
May 2, 2025
Maintains: Buy
Price Target: $152 → $139
Current: $137.70
Upside: +0.94%
DexCom
May 2, 2025
Maintains: Buy
Price Target: $103 → $106
Current: $84.67
Upside: +25.19%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $58 → $59
Current: $22.98
Upside: +156.75%
Edwards Lifesciences
Apr 25, 2025
Maintains: Hold
Price Target: $71 → $75
Current: $73.68
Upside: +1.79%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $4.77
Upside: +277.36%
TriSalus Life Sciences
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.02
Upside: +119.12%
AtriCure
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $31.00
Upside: +67.74%
TransMedics Group
Mar 11, 2025
Maintains: Buy
Price Target: $104
Current: $111.50
Upside: -6.73%
Neuronetics
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $4.43
Upside: +80.59%
CeriBell
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $15.97
Upside: +106.64%
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $55.82
Upside: +80.94%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $310.67
Upside: -2.15%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $102.86
Upside: -1.81%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $6.68
Upside: +124.55%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $9.11
Upside: +31.72%
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $95.21
Upside: +20.79%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $297.32
Upside: -4.48%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $12.21
Upside: +104.75%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $3.37
Upside: +256.08%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $95.83
Upside: -26.95%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $19.42
Upside: +147.17%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $3.89
Upside: +465.55%